Alzheimer's disease & dementia

LSL60101 compound reduces neuroinflammation and improves cognition

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease. This is stated in the recent studies by the Research Group ...

Oncology & Cancer

Discovering the secrets of tumor growth

Scientists at the University of Copenhagen's Center for Healthy Ageing have identified a compound that blocks the expression of a protein without which certain tumours cannot grow. This compound has the potential as an anticancer ...

Diseases, Conditions, Syndromes

A new target in the fight against TB

(Medical Xpress)—Researchers have identified a potential new route for attacking tuberculosis that may hold promise against drug-resistant strains of the disease and even dormant TB infections.

page 28 from 33